Peter Marks, the Food and Drug Administration (FDA) official pressured to resign over his disagreements with Health and Human ...
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
Amgen (AMGN) announced that the U.S. FDA has approved Uplizna as the first and only treatment for adults living with Immunoglobulin G4-related ...
The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Android Central on MSN9d
Quiet Wear OS 5.1 QoL update brings app icons to Pixel Watch tilesPixel Watches have reportedly gained a small, QoL update for tiles alongside the recent Wear OS 5.1 update. Tiles now display ...
Makary earlier this month distanced himself from the recent shake-ups at the FDA, including the cancellation of its vaccines ...
Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...
US FDA Expands Approval for Alnylam's Drug to Treat Rare Heart Disease By Bhanvi Satija and Sneha S K (Reuters) -U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and ...
NEW YORK — Akero Therapeutics may not have adequate data for accelerated approval of its MASH drug, despite showing it may reverse cirrhosis in patients with … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback